Effectiveness on urinary symptoms and erectile function of Prostamev Plus® vs only extract Serenoa repens
Authors:
Open Access
- 31 March 2015
- journal article
- research article
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 87 (1) , 25-27
Abstract
Prostatic inflammation is widespread in the male population. Two groups of 50 patients each with symptoms of prostatic inflammation and ecocolorDoppler indicative of prostatitis were identified. Both groups were further subdivided into two subgroups (respectively A1, A2, B1, and B2). Group A1 underwent therapy with oral levofloxacin 500 mg daily for 10 days plus co-treatment with oral Serenoa repens (320 mg) plus Bromeline plus Nettle (Prostamev Plus®) daily for two months; Group A2 with oral levofloxacin 500 mg daily for 10 days plus oral Serenoa repens extract 320 mg/day for two months; Group B1 specific antibiotic treatment for 10 days (included levofloxacin if sensitive) plus co-treatment with oral Serenoa repens (320 mg) plus Bromeline plus Nettle (Prostamev Plus®) daily for two months; Group B2 with specific antibiotic treatment for 10 days plus Serenoa repens 320 mg/day for two months. The groups treated with Prostamev Plus® in comparison to the groups treated with Serenoa repens extract (saw palmetto) achieved better improvements of both IPSS score, urinary flow and sexual life.Keywords
This publication has 7 references indexed in Scilit:
- Associating Serenoa Repens, Urtica Dioica and Pinus Pinaster. Safety and Efficacy in the Treatment of Lower Urinary Tract Symptoms. Prospective Study on 320 PatientsUrologia Journal, 2010
- Re: Serenoa repens associated with Urtica dioica (ProstaMEV®) and curcumin and quercitin (FlogMEV®) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised studyInternational Journal of Antimicrobial Agents, 2009
- Serenoa repens associated with Urtica dioica (ProstaMEV®) and curcumin and quercitin (FlogMEV®) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised studyInternational Journal of Antimicrobial Agents, 2009
- Saw Palmetto for Benign Prostatic HyperplasiaNew England Journal of Medicine, 2006
- The role of a lipido‐sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasiaBJU International, 2004
- 349 Evaluation of the clinical benefit of Permixon and Tamsulosin in severe BPH patients. Permal study sub-set analysisEuropean Urology Supplements, 2004
- Phytotherapy in treatment of benign prostatic hyperplasia: a critical reviewUrology, 1996